GB1206790A - Organo-silicon complexes and preparation thereof - Google Patents

Organo-silicon complexes and preparation thereof

Info

Publication number
GB1206790A
GB1206790A GB5777467A GB5777467A GB1206790A GB 1206790 A GB1206790 A GB 1206790A GB 5777467 A GB5777467 A GB 5777467A GB 5777467 A GB5777467 A GB 5777467A GB 1206790 A GB1206790 A GB 1206790A
Authority
GB
United Kingdom
Prior art keywords
acid
compounds
anion
pharmaceutical
dec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5777467A
Inventor
Charles Henri Jean Gueyne
Marie Irene Duffaut
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR88728A external-priority patent/FR6871M/fr
Priority claimed from FR88729A external-priority patent/FR92263E/en
Application filed by Individual filed Critical Individual
Publication of GB1206790A publication Critical patent/GB1206790A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0834Compounds having one or more O-Si linkage
    • C07F7/0836Compounds with one or more Si-OH or Si-O-metal linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)

Abstract

1,206,790. Pharmaceutical and cosmetic compositions comprising organosilicon compounds. C. H. J. GUEYNE and M. I. DUFFAUT. 20 Dec., 1967 [23 Dec., 1966 (2)], No. 5.7774/67. Addition to 955969. Heading A5B. [Also in Division C3] Pharmaceutical and cosmetic compositions comprise as active ingredient an organosilicon complex of the general formula in which R is an organic group, other than an acid or salt thereof, which may contain functional groups, x is 0 to 3, Y is the anion of a mineral or organic acid or of any salt-forming organic compound that affords an anion. Me is sodium or potassium, and a, b and c are finite numbers. Examples of these compounds are CH 3 Si(OH) 3 .C 7 H 5 O 3 Na, Y being derived from salicylic acid; CH 3 Si (OH) 3 .C 6 H 9 O 7 Na, Y being derived from mannuronic acid; and similar compounds in which the anion is from citric acid and phenol. The compounds may be used in aqueous solution and may be used in admixture with an antibiotic, e.g. penicillin or streptomycin. The mannuronate derivative is particularly useful in creams, lotions, milks or foam baths. The pharmaceutical preparations may be applied by intramuscular, intravenous, oral, rectal or percutaneal methods or by electrophoresis. The compositions may be used as eyebaths and in application pads and are stated to be effective against a variety of diseases.
GB5777467A 1966-12-23 1967-12-20 Organo-silicon complexes and preparation thereof Expired GB1206790A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR88728A FR6871M (en) 1966-12-23 1966-12-23
FR88729A FR92263E (en) 1959-05-12 1966-12-23 Manufacturing process of organo-silicic complexes, complexes obtained and their applications

Publications (1)

Publication Number Publication Date
GB1206790A true GB1206790A (en) 1970-09-30

Family

ID=26174421

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5777467A Expired GB1206790A (en) 1966-12-23 1967-12-20 Organo-silicon complexes and preparation thereof

Country Status (8)

Country Link
BE (1) BE708383A (en)
CA (1) CA922703A (en)
CH (1) CH488736A (en)
DE (1) DE1668171A1 (en)
DK (2) DK131503B (en)
GB (1) GB1206790A (en)
NO (1) NO127402B (en)
SE (1) SE349046B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003434A1 (en) * 1984-02-06 1985-08-15 Neutrogena Corporation Vehicle for delivering active pharmaceutical ingredientsto the h uman skin
GB2159408A (en) * 1984-03-30 1985-12-04 Lion Corp Humectant
US4563347A (en) * 1982-05-20 1986-01-07 Dow Corning Corporation Compositions used to condition hair
US4784844A (en) * 1979-12-03 1988-11-15 General Electric Company Volatile silicone-water emulsions and methods of preparation and use
EP1468693A2 (en) * 1993-12-10 2004-10-20 Merrell Pharmaceuticals Inc. Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus
WO2008084268A1 (en) 2007-01-11 2008-07-17 Mta Szegedi Biológiai Központ Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions
EP3666249A1 (en) 2018-12-10 2020-06-17 Jednostka Innowacyjno-Wdrozeniowa INWEX Spolka z Ograniczona odpowiedzialnoscia Complexes of organic silicon compounds with boron citrate and dimethylethanolamine

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510407A1 (en) * 1981-07-28 1983-02-04 Duffaut Charles Organo-silanol and adenosine phosphoric acid deriv. compsn. - for cellulitis treatment by ionokinesis, opt. contain organic acids
BE1023898B1 (en) 2016-08-25 2017-09-07 Sil'innov Scrl Composition comprising silicon and its method of preparation

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784844A (en) * 1979-12-03 1988-11-15 General Electric Company Volatile silicone-water emulsions and methods of preparation and use
US4563347A (en) * 1982-05-20 1986-01-07 Dow Corning Corporation Compositions used to condition hair
WO1985003434A1 (en) * 1984-02-06 1985-08-15 Neutrogena Corporation Vehicle for delivering active pharmaceutical ingredientsto the h uman skin
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
GB2159408A (en) * 1984-03-30 1985-12-04 Lion Corp Humectant
EP1468693A2 (en) * 1993-12-10 2004-10-20 Merrell Pharmaceuticals Inc. Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus
EP1468693A3 (en) * 1993-12-10 2004-11-03 Merrell Pharmaceuticals Inc. Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus
WO2008084268A1 (en) 2007-01-11 2008-07-17 Mta Szegedi Biológiai Központ Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions
CN101631552B (en) * 2007-01-11 2013-08-07 匈牙利制药2000有限公司 Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions
EP3666249A1 (en) 2018-12-10 2020-06-17 Jednostka Innowacyjno-Wdrozeniowa INWEX Spolka z Ograniczona odpowiedzialnoscia Complexes of organic silicon compounds with boron citrate and dimethylethanolamine

Also Published As

Publication number Publication date
CH488736A (en) 1970-04-15
DK131503C (en) 1975-12-29
SE349046B (en) 1972-09-18
CA922703A (en) 1973-03-13
DK126234B (en) 1973-06-25
DE1668171A1 (en) 1974-08-29
NO127402B (en) 1973-06-18
BE708383A (en) 1968-05-02
DK131503B (en) 1975-07-28

Similar Documents

Publication Publication Date Title
GB1475251A (en) Oral preparations
GB1206790A (en) Organo-silicon complexes and preparation thereof
BE616919A (en) Process for the preparation of acid derivatives
GB1003595A (en) Oral compositions for caries prophylaxis
CH436246A (en) Process for the preparation of transchrysanthemum acid derivatives
GB1101423A (en) Derivatives of 7-aminocephalosporanic acid
GB1185096A (en) Improvements in or relating to Antibiotic Derivatives and the manufacture thereof
FR1428402A (en) Process for the preparation of addition compounds containing formic acid
JPS5626814A (en) Antibacteria agent and its use
GB1096523A (en) Cosmetic composition
GB1427508A (en) Pyrido pyrimidine compounds
GB1421562A (en) Pesticidal thiophosphoric acid esters
GB1260227A (en) Cosmetic compositions
GB943943A (en) Shaving preparations comprising pilo-motor active compounds
GB1302679A (en)
GB1111275A (en) Cytosamine derivatives
GB1197035A (en) Hair Treatment Compositions
IE33161L (en) Detergent
GB1252993A (en)
GB1238095A (en)
CA925860A (en) Preparation of unsaturated compounds by hydrolysis of xanthate-lewis acid complexes
GB1319402A (en) 3-acyloxypropyl-2,-trimethylammoniumethyl phosphates
GB980016A (en)
ES382240A1 (en) Hydroxyisoquinuclidine derivatives
GB1275152A (en) Acyloxyalkylmercapto compounds and process for their manufacture

Legal Events

Date Code Title Description
PS Patent sealed
435 Patent endorsed 'licences of right' on the date specified (sect. 35/1949)
PE Patent expired